On January 22, Douglas Lane & Associates disclosed a sale of 65,461 shares of Lamb Weston Holdings (LW 6.74%) for an estimated $3.85 million based on quarterly average pricing.
What happened
According to an SEC filing dated January 22, Douglas Lane & Associates sold 65,461 shares of Lamb Weston during the fourth quarter. The estimated value of this trade is $3.85 million, calculated using the average closing price for the quarter. At quarter-end, the fund held 1,213,884 shares of Lamb Weston valued at $50.85 million. The position's value fell by $23.45 million over the period, reflecting both sales and price changes.
What else to know
Top holdings after the filing:
- NASDAQ:GOOGL: $314.35 million (4.4% of AUM)
- NASDAQ:NVDA: $294.52 million (4.1% of AUM)
- NASDAQ:QCOM: $167.19 million (2.3% of AUM)
- NASDAQ:MSFT: $167.18 million (2.3% of AUM)
- NYSE:MS: $142.12 million (2.0% of AUM)
As of January 21, shares of Lamb Weston were priced at $44.32, down 27.5% over the past year and lagging the S&P 500 by 41.14 percentage points.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $6.47 billion |
| Net Income (TTM) | $392.30 million |
| Dividend Yield | 3.5% |
| Price (as of 2026-01-21) | $44.32 |
Company snapshot
- Lamb Weston Holdings produces and markets value-added frozen potato products, commercial ingredients, and appetizers globally under owned and licensed brands.
- The company generates revenue primarily through sales of frozen potato products to foodservice and retail customers worldwide.
- It serves retail and foodservice operators, including grocery chains, mass merchants, restaurants, and convenience stores worldwide.
Lamb Weston Holdings, Inc. is a leading global supplier of frozen potato products, operating across multiple distribution channels with a diverse customer base. The company leverages its scale, brand portfolio, and integrated production capabilities to maintain a strong presence in the packaged foods sector.
What this transaction means for investors
Against a portfolio dominated by mega-cap growth and financials, reducing exposure here looks less like a loss of conviction and more like risk management. Lamb Weston’s latest quarter showed signs of operational stabilization. Fiscal Q2 net sales rose 1% year over year to $1.62 billion, while net income swung sharply positive to $62.1 million from a loss of $36.1 million a year earlier. Management reiterated full-year guidance, targeting $6.35 billion to $6.55 billion in sales and up to $1.20 billion in adjusted EBITDA, and raised the quarterly dividend by 3%. That’s not the profile of a business in distress.
But the market has been unforgiving. Shares are down roughly 28% over the past year, underperforming the S&P 500 by more than 40 points. Pricing pressure, customer concessions, and uneven international utilization continue to weigh on sentiment. Long-term investors should watch whether cost savings and volume gains translate into sustained margin expansion before expecting a rerating.
